longitudecapital.com
Longitude Capital: Venture Growth Investing in Life Sciences
http://www.longitudecapital.com/portfolio.html
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi...Following...
longitudecapital.com
Longitude Capital: Venture Growth Investing in Life Sciences
http://www.longitudecapital.com/news.html
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi...Following...
nlvpartners.com
New Leaf Venture Partners - Portfolio
http://www.nlvpartners.com/portfolio.html
With the success of our entrepreneurs our portfolio has. 20 billion-dollar companies, 34 acquired companies,. And 39 companies taken public, with more to come. Artificial intelligence platform that confirms medication adherence in clinical trials and high-risk patient populations. New York, NY. Platform for small-molecule drugs that induce targeted degradation of disease-causing intracellular proteins. New Haven, CT. NLV III / GROWTH. NLV III / GROWTH. NLV III / GROWTH. Berkeley Heights, NJ. New York, NY.
longitudecapital.com
Longitude Capital: Venture Growth Investing in Life Sciences
http://www.longitudecapital.com/working_us.html
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi...Following...
longitudecapital.com
Longitude Capital: Venture Growth Investing in Life Sciences
http://www.longitudecapital.com/our_team.html
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi...Following...
longitudecapital.com
Longitude Capital: Venture Growth Investing in Life Sciences
http://www.longitudecapital.com/our_approach.html
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi...Following...
longitudecapital.com
Longitude Capital: Venture Growth Investing in Life Sciences
http://www.longitudecapital.com/index.html
Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. We invest in both privately held and publicly traded life science companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi...Following...
